Todas as matérias desta categoria, das mais recentes às mais antigas.
Lori Calvasina, head of US equity strategies at RBC, discusses earnings risks for stocks from the artificial intelligence buildout and what her firm sees on technology capex outside of the top 10 markets cap names in the S&P 500.
Hain Celestial (NASDAQ:HAIN) agreed to sell the majority of its International business to private equity firm AURELIUS for approximately $323 million in cash as part of its strategic transformation plan.
Radiopharm Theranostics (NASDAQ:RADX) reported that RAD101 PET achieved 93% concordance with MRI across all evaluable lesions in an interim Phase 2b analysis, meeting the imaging trial’s primary endpoint.
Perspective Therapeutics entered a clinical trial collaboration and supply agreement with Merck (NYSE:MRK) to evaluate targeted alpha therapy PSV359 in combination with Keytruda in FAP-α-positive solid tumors.
WisdomTree (NYSE:WT) reported record assets under management of approximately $174 billion globally at the end of August 2026, supported by strong client demand and continued inflows across its investment products.
The Elmet Group (NASDAQ:ELMT) plans to deploy a committed $450 million U.S. Department of War investment to develop a more vertically integrated tungsten supply chain.
Digital Realty (NYSE:DLR) formed a strategic joint venture with Rönesans Infrastructure to develop and operate next-generation, carrier-neutral data centers across Türkiye.
Bloomberg Opinion columnist Parmy Olson discusses Anthropic PBC Chief Executive Officer Dario Amodei's proposal that AI labs should slow down their most cutting-edge research. "Pacing or slowing down does also just essentially kick the can down the road," Olson says on Bloomberg Television. "Dario's essay was quite vague in terms of how he thinks that should happen."
Brent crude for October and November delivery rose more than 3% above $108 a barrel Monday, while U.S. benchmark WTI gained 2.3% to around $102.
The UAE's post-pandemic boom is being tested by a war showing few signs of resolution, as disruption in the Strait of Hormuz drives up import costs and fuel prices. Yet the economy is showing signs of resilience. Bloomberg's Zainab Fattah reports.
BioNTech (NASDAQ:BNTX) and OncoC4 reported updated Phase 3 PRESERVE-003 data showing median overall survival of 18.5 months with gotistobart versus 10.0 months with docetaxel in previously treated squamous NSCLC.
Maria Municchi, multi asset fund manager at M&G Investments, discusses the outlook for the artificial intelligence trade after leaders of the biggest firms proposed slowing the technology's development. She tells Bloomberg Television that while "price will continue to behave pretty well," markets are becoming "a little bit more wary" about whether the capex boom will translate into delivered earnings.
